Patent Expirations Set Biopharma on a Tough Path for 2026
Biopharma Faces a Critical Year Ahead The biopharma industry is entering 2026 with uncertainty, as patent expirations on blockbuster drugs are expected to reshape the […]
Skip to content
You May Also Like:
AI Is Redefining the Future of Research Labs
AI Revolutionizes the Modern R&D Lab The design of research and development labs is undergoing a dramatic shift as artificial intelligence and automation become central […]
Rare Disease Drug Sales to Exceed $400 Billion by 2032
Rare Disease Drugs Drive Pharma Growth Despite Challenges The rare disease drug market is on track for remarkable expansion, with global sales expected to surpass […]
Patent Expirations Set Biopharma on a Tough Path for 2026
Biopharma Faces a Critical Year Ahead The biopharma industry is entering 2026 with uncertainty, as patent expirations on blockbuster drugs are expected to reshape the […]
PMA Warns of 50,000 New Kidney Failure Cases in Pakistan
Kidney Failure Cases Expected to Surge in 2026 The Pakistan Medical Association (PMA) has sounded the alarm over a potential surge in kidney failure cases, […]
Government Reaffirms Support for CPSP’s Role in Medical Training
PMDC and CPSP Strengthen Medical Education and Global Collaboration On March 12, 2026, Federal Minister of Health Syed Mustafa Kamal met with a high-level delegation […]
Talat’s Injury Scare Shocks Pakistan Team
Hussain Talat Injured During Pakistan vs Bangladesh ODI Pakistan’s ODI campaign against Bangladesh took a worrying turn when all-rounder Hussain Talat suffered a painful injury […]